09.10.2020 • News

Lummus wins Uzbek Ethylene Project

Lummus Technology has been awarded a contract by Enter Engineering for the Shurtan Gas Chemical Complex in Uzbekistan. Lummus Technology’s scope includes the design and supply of four proprietary Short Residence Time (SRT) VI- and VII-type cracking furnaces, which will more than double ethylene output at the facility. The company did not disclose the complex’s ethylene capacity nor gave a timescale for the project.

“We are grateful to continue our partnership at Shurtan and look forward to working with Enter Engineering to expand the ethylene production while reducing relative emissions and operating costs at the Shurtan Gas Chemical Complex,” said Lummus Technology president and CEO Leon de Bruyn, who added that the SRT furnaces “optimize reliability in capacity, yield, run-length and energy efficiency.”
 
The US process licensing group said it was selected due to its leading ethylene technology position and its extensive experience with ethylene furnaces. Lummus claims to have provided more ethylene furnaces than any other process licensor, representing more than 40% of global capacity.

 

Author: Elaine Burridge, Freelance Journalist

Lummus Technology has won a contract from Enter Engineering for the Shurtan Gas...
Lummus Technology has won a contract from Enter Engineering for the Shurtan Gas Chemical Complex in Uzbekistan. Lummus’s scope includes the design and supply of four proprietary Short Residence Time VI- and VII-type cracking furnaces, which will more than double ethylene output. (c) Life Of Pix from Pexels

Company

Logo:

Lummus Technology

5825 North Sam Houston Pkwy W #600
77086 Houston, TX
US

Company contact







From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.